Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 February 2005, Vol. 105, No. 3, pp. 912.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chamaillard, M.
Right arrow Articles by Nuñez, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Chamaillard, M.
Right arrow Articles by Nuñez, G.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow


InsideBlood

IMMUNOBIOLOGY

Comment on Kanazawa et al, page 1195

Early-onset sarcoidosis gets the nod

Mathias Chamaillard, Christine McDonald, and Gabriel Nuñez

THE UNIVERSITY OF MICHIGAN MEDICAL SCHOOL

Missense mutations of Nod2/CARD15 are associated with the development of Blau syndrome. Kanazawa and colleagues provide evidence that similar mutations of Nod2 are associated with early-onset sarcoidosis, demonstrating a casual link between these 2 diseases.

In response to pathogen exposure, vertebrates have evolved multiple immune defense systems to eliminate the invasive microbe. However, genetic mutations in the molecules involved in these responses can lead to inappropriate immune responses and result in inflammatory disease. In this issue of Blood, Kanazawa and colleagues demonstrate a genetic link between missense mutations of one such immune defense molecule, Nod2, and the inflammatory disease early-onset sarcoidosis (EOS).

The sensing of microbial agents by the host is mediated through pathogen-recognition molecules (PRMs) that are activated by highly conserved structures uniquely found in microbes. A major class of PRMs is the Toll-like receptors (TLRs), which upon activation induce intracellular signaling pathways leading to microbicidal host responses. Another more recently identified class of PRMs is the nucleotide-binding oligomerization domain (NOD)–containing proteins (Nods). Unlike TLRs, Nods are primarily located inside the cell and sense microbial products in the cytosol.Go



Model of Nod2 signaling in health and disease.

 

Mutations in the coding region of a Nod family member, Nod2/Card15, have been implicated in 2 diseases characterized by granulomatous inflammation. Three major Nod2 mutations, R702W, G908R, and L1007fsinsC, as well as multiple rare variants, have been found to be associated with susceptibility to Crohn disease (CD), a chronic inflammatory bowel disease.1 These CD-associated Nod2 variants are deficient in their ability to sense muropeptides, the bacterial molecules recognized by Nod2.1,2 Upon stimulation, Nod2 activates signaling pathways, including nuclear factor–{kappa}B (NF-{kappa}B; see figure). In addition to CD, several missense mutations of Nod2 have been associated with the development of Blau syndrome (BS), a dominantly inherited disease characterized by early-onset arthritis, uveitis, and skin rashes.3

EOS is another rare but sporadic disease and shares several clinical and pathologic features with BS. This similarity suggests that both syndromes might represent hereditary and sporadic forms of the same disease. However, genetic evidence linking BS and EOS was lacking until now. The paper by Kanazawa and colleagues demonstrates that missense mutations of Nod2 are associated with the development of EOS, including the R334W mutation that was previously found in patients with BS.3 As previously reported for BS-associated proteins,2,4 all of the EOS-associated gene variants act as constitutively active Nod2 mutants. The disease-causing Nod2 mutations involved residues located in the NOD domain. The NOD domain is critically involved in oligomerization and activation of Nod2, suggesting that these mutations may stabilize the active conformation of Nod2. Notably, 4 of the 5 EOS-causing Nod2 mutations (R334W, D382E, M513T, and N670C) correspond to the mutated residues R260Q, D303N, A439V, and Y570C in cryopyrin, another Nod protein whose missense mutations are associated with development of inherited autoinflammatory disorders.1 There appears to be minor genetic heterogeneity within EOS, as no amino acid alterations of Nod2 have been found in 1 of the 10 reported Japanese patients and in 2 European patients originally reported by Miceli-Richard et al.3 Better understanding of the Nod2 signaling pathway might lead to more rational and successful treatments of Nod2-associated diseases. {blacksquare}

References

  1. Inohara N, Nuñez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol. 2003;3: 371-382.[CrossRef][Medline] [Order article via Infotrieve]

  2. Chamaillard M, Philpott D, Girardin SE, et al. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci U S A. 2003; 100: 3455-3460.[Abstract/Free Full Text]

  3. Miceli-Richard C, Lesage S, Rybojad M, et al. CARD15 mutations in Blau syndrome. Nat Genet. 2001;29: 19-20.[CrossRef][Medline] [Order article via Infotrieve]

  4. Tanabe T, Chamaillard M, Ogura Y, et al. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J. 2004;23: 1587-1597.[CrossRef][Medline] [Order article via Infotrieve]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-{kappa}B activation: common genetic etiology with Blau syndrome
Nobuo Kanazawa, Ikuo Okafuji, Naotomo Kambe, Ryuta Nishikomori, Mami Nakata-Hizume, Sonoko Nagai, Akihiko Fuji, Takenosuke Yuasa, Akira Manki, Yoshihiko Sakurai, Mitsuru Nakajima, Hiroko Kobayashi, Ikuma Fujiwara, Hiroyuki Tsutsumi, Atsushi Utani, Chikako Nishigori, Toshio Heike, Tatsutoshi Nakahata, and Yoshiki Miyachi
Blood 2005 105: 1195-1197. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chamaillard, M.
Right arrow Articles by Nuñez, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Chamaillard, M.
Right arrow Articles by Nuñez, G.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020